As Singapore extends its semi-lockdown to June 1 in response to a wave of new coronavirus cases, local biotech firms are racing to develop tests and treatments to help in curbing the spread of COVID-19.
Singapore’s Biolidics Limited is betting big on its COVID-19 rapid test kits after clearing regulatory hurdles from the health authorities in Singapore, the Philippines and the European Union.